SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-22-014723
Filing Date
2022-01-21
Accepted
2022-01-21 15:25:59
Documents
2
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA SELGMAN TECHNOLOGY & INFORMATION FUNDSELIGMAN TECH SPECTRUM OFFSHORE FUND

Document Format Files

Seq Description Document Type Size
1 SC 13D d301187dsc13d.htm SC 13D 87073
2 EX-99.I d301187dex99i.htm EX-99.I 124966
  Complete submission text file 0001193125-22-014723.txt   214138
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87931 | Film No.: 22545782
SIC: 2836 Biological Products, (No Diagnostic Substances)